chrisvoncsefalvay/vaers-outcomes huggingface dataset:
received the first dose of the Moderna COVID-19 vaccine and then got COVID; a cough that got worse everyday; did not get the second dose of the vaccine when they were scheduled; bad headache; bad body aches; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Sep-2021 and was forwarded to Moderna on 01-Sep-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (received the first dose of the Moderna COVID-19 vaccine and then got COVID), COUGH (a cough that got worse everyday), PRODUCT DOSE OMISSION ISSUE (did not get the second dose of the vaccine when they were scheduled), HEADACHE (bad headache) and MYALGIA (bad body aches) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SUSPECTED COVID-19 (received the first dose of the Moderna COVID-19 vaccine and then got COVID), COUGH (a cough that got worse everyday), PRODUCT DOSE OMISSION ISSUE (did not get the second dose of the vaccine when they were scheduled), HEADACHE (bad headache) and MYALGIA (bad body aches). At the time of the report, SUSPECTED COVID-19 (received the first dose of the Moderna COVID-19 vaccine and then got COVID), COUGH (a cough that got worse everyday), HEADACHE (bad headache) and MYALGIA (bad body aches) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (did not get the second dose of the vaccine when they were scheduled) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Aug-2021, SARS-CoV-2 test positive: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and Concomitant medications not reported by reporter.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. The patient's medical history included ophthalmic herpes. No drug allergy and no concomitant medication. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, frequency, lot # and indication were not reported). The patient was diagnosed with a recurrence of ophthalmic herpes simplex 2-3 days after administration of ZOSTAVAX. The patient, who had a pre-existing history of ophthalmic herpes, was administered ZOSTAVAX 2-3 days ago at another facility. She was evaluated by an unspecified ophthalmologist and was prescribed VALTREX. The patient sought medical attention. The outcome of event was reported as not recovered/not resolved. Additional information is not expected.
Patient received FLUVIRIN. Approximately 5 minutes post-injection, pt reported tingling tongue. Pt also presented with a slightly visible foaming of mouth. Pt is an oral cancer survivor. We immediately called 911, however pt's vitals OK (slightly high BP). Pt left on her own and appeared O.K. Pt was evaluated by EMS!
Pt completed 2 dose of COVID 19 (Pfizer) vaccine. She did not develop any side effects after her first dose, but developed acute on chronic migraine HA, nausea, low grade fever, and back pain after her 2nd shot. On the day of the 2nd shot (01/29/21), she did not have any symptoms, but woke up the next day (1/30/21) with symptoms. Her symptoms persisted after more than one week.
cognitive issue (dementia); This is a spontaneous report from a non-contactable consumer. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on 05Feb2021, at a single dose, for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Feb2021, the patient experienced cognitive issue (dementia). The patient wanted to know about her second dose schedule. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received concerning his son who was vaccinated with with varicella vaccine first dose. In May or June 2000 his son experienced a mild case of shingles with vesicular patch on his left buttock. The rash appeared vesicular with a dermatomal distribution of L5/S1. There were dozens of lesions. He noted that the child was afebrile and had no other systemic symptoms. it was indicated that the pt did not have any recent exposure to natural chickenpox or shingles and that a rash did not occur at the site of injection or elsewhere within 42 days of the vaccination. Additionally, it was reported that the lesions have healed. The pt sought unspecified medical attention.
On January 26, 2023, I climbed the stairs and felt like my heart was beating out of my chest. I usually climb four flights of stairs at work, but I had to take the elevator the rest of the way. Prior to this, my smart watch showed my heart was jumping to the rate of 130 beats per minute while walking normally. My chest felt like funny, but it was not painful. I didn't feel like I was going to pass out either. On February 10, 2023, I saw my doctor. They did an EKG. They found some PVC. They ordered a 24-hour heart monitor and prescribed propranolol. They also took labs. They also performed a Heart Echo. There were no significant findings. I requested a Cardiac CT due to family history of heart attack. My labs showed low on iron, but everything else was normal. On March 16, 2023, I had the Cardiac CT. It showed Zero Coronary Calcium Score, but there was soft plaque. I also had a Stress Test on April 7, 2023. There was no evidence of Ischemia. I have a Cardiological Consultation on April 26, 2023. Since then, I am taking propranolol twice a day, atorvastatin once a day, and baby aspirin.
Dizziness, Tachycardia,  NEAR SYNCOPAL;  Narrative:
Mycrocarditis, truponin levels were at 20,   Diahreah  , chest pain, back pain -1 werk
Lump/knot in armpit area on same arm as shot; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 20Apr2021 at 14:00 (at the age of 39-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 11May2021 at 18:30 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06May2021 at 07:00, the patient experienced lump/knot in armpit area on the same arm as shot. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event lump/knot in armpit area was not recovered at the time of the report.  No follow-up attempts are needed. No further information is expected.
I had severe diarrhea and vomiting for about 24 hours. I went to the ER while on a trip and got IV fluids there. The tested me for COVID-19 and the Flu and it was negative. They gave me fluids and medicine to slow down the symptoms. At the end of the 24 hour period I started coughing and respiratory symptoms. A week later we came back home, I couldn't eat, swallow, and lost my voice. I had deep achiness and went to the ER here locally. On February 13 I was admitted to the hospital and released on the 14th. I had low blood pressure, a UTI, low calcium and dehydration and a severe low cough. After I was discharged the weeks following, I was mostly treated for coughing with prescription cough medicine. The severe fatigue lasted for about four weeks now it's more periodic fatigue. I am very tired now. Also I am having abdominal pain and periodic stomach pains. The other symptoms of coughing all gone just fatigue. In the hospital while on the trip they didn't detect Influenza B, but they picked it up in my local HCF.
Allergic reaction to TDAP. cleared by med. evaluator, Spoke to patient. 30 min wait. While in recovery after 20 min after vaccine pt complained of "lump in throat and feeling warm" no LOC, no SOB AAO. No tongue swelling, no lip swelling + diaphoresis. Lung sounds clear = bialterally, no wheezing no difficulty wheezing. MD assessed surmised mild anxiety Globus Hystericus.  Left deltoid site benign no redness, no swelling, no hives no LOC, no syncope. Ice pack to back of neck. 1:55 pm VS 160/90, HR 96, resp 14 reg non labored, 99% O2 Sat. Monitored 45 min, water for hydration, provided reassurance no further complaints.  2:08 pm 130/85, HR 80, resp 12 reg non labored, O2 sat 99%. Pt stated "feel much better, I'm OK.  OK'd to exit. walked to door.
Initial report received from a health care professional on 01 Sep 2010: On 01 Sep 2010, this patient was vaccinated with only the Men CWY-135 liquid conjugate component of MENVEO (batch number: 028011), unknown intramuscularly without being reconstituted with the Men A conjugate component. No adverse events were noted following this medication error. Follow up report received from the nurse on 20 Sep 2010: It was reported that the patient received 0.5 ml, Men CWY-135 liquid conjugate component of MENVEO on 25 Aug 2010. The patient had not experienced any adverse events post vaccination. The case was assessed as non serious.
Rash on right buttock, diagnosed as Shingles (Herpes Zoster)
Vomiting 1/2 hour. Followed by erythema and swelling of face, peri oral.>???????? Tx in ER solumedrol, epinephrine, and steroids PO.
Patient returns to pharmacy approximately 2 & half weeks later (10/4/2012) with a little bit better than a quarter size of bruise at the injection site. No pain or other side effect reported, except the bruise.
After 7 days of vaccine: Headache, chills, fever, swatting, chest pain, strong heart palpitations
Information has been received from a lawyer regarding a case in litigation concerning a male minor child who in 1994 was vaccinated with hep B vaccine recombinant. Concomitant therapy included HIB conjugate vaccine (HIBTITER) in 1994; Tripedia and HIB conjugate vaccine Haemophilus B conjugate vaccine (ACTHIB) in 1994 and 1995 and Acel-Imune in 1999. It has been alleged that through these vaccinations administered to the pt during the first several years of his life, he received very high doses of mercury contained in thimerosal, a highly toxic preservative. It has been further alleged that as a result of the mercury in the thimerosal containing vaccinations received during these developmental years, the pt suffered and in the future will continue to suffer from the toxic neurological effects of mercury poisoning, including but not limited to autism. Upon internal review, toxic neurolgoical effects, mercury poisoning, and autism were considered other important medical events (OMIC). No further info is available.
On  04/28/2021 - started feeling brain fog.  Nausea. Several times I felt like I am having an out of body experience and I become easily agitated
Initial report received from a consumer on 30 November 2011. A female patient (age refused to be provided) received a right arm intramuscular injection of FLUZONE, sanofi pasteur Inc. lot number UT440AA, on 25 November 2011. On 25 November 2011, within one hour of receiving the FLUZONE, the patient developed respiratory distress with wheezing and felt like this increased her asthma symptoms. She also complained of headache, fever "104 - 110 degrees Fahrenheit", pain in right arm and itching at the injection site. The patient self medicated with TYLENOL, BENADRYL and asthma inhaler. The outcome was reported as not recovered. Documents held by sender: None.
The day after I received the vaccine I had a rash the size of a golf ball. It itched a little and was very warm to the touch.  The rash cleared by Jan 9th and on the 10th I woke up and noticed I had shingles on the left arm, on the outside next to my arpit. This was the same arm that I had the vaccine and rash. It is also about the size of a golf ball. I have been using Hydrochrotozone Cream 1% OTC once a day. I also start antivirals on the 10th. Acyclovir 400 mg PO TID.  The only reason why I know this is Shingles, was do to a similar experience in 2017 I recieved my Hep A &B,  and oral Typhoid for missions trip to Haiti. We were there for 5 days and the day I got back I had a rash on both sides of my body from my armpit to my waist. The doctors had trouble trying to figure out what it was. I also went to a dermatologist and they had not clue. Until months later my travel doctor figured it out. He told me it was shingles and had me start taking antivirals.  After a week or so the rash cleared up with the antivirals. This rash presents in the same manner as it did then. So I started taking my antivirals again. The rash is still there currently. I am not sure if the COVID vaccine and the other vaccines have similar properties? I am not sure if it is related, however it does seem to be. I have only had the 1st shot so I am not sure if I should go ahead with the second one.
COVID19 Moderna patients involved- 57 patients COVID19 Pfizer patients involved- 89 patients  Patients received the monovalent booster after the EUA was revoked.
Blood clot in leg; This case was reported by a pharmacist via call center representative and described the occurrence of thrombosis leg in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In June 2022, the patient received the 1st dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced thrombosis leg (serious criteria GSK medically significant). On an unknown date, the outcome of the thrombosis leg was not recovered/not resolved.   It was unknown if the reporter considered the thrombosis leg to be related to Shingrix.     Additional Information: GSK receipt date: 23-SEP-2022 Reporters comment: The patient was not immunocompromised.  The pharmacist called to see if it was safe to administer Shingrix second dose if a patient had a blood clot on her leg.  At the moment of the reporting, Shingrix second dose had not been administered. The reporter did not consent to follow-up as consent was not possible to obtain during the call.
Pt to lobby with c/o itching, redness, at injection site. Pt c/o N, V, D with s/s starting in the PM hours after vaccine administration on 11/06/2012.
Acute onset of seizures on 6-30-16 while at park. Fever upon arrival to ER. Status epilepticus admitted to PICU. Fever lasted for 3 days. Developed rash on 7-02-16 that lasted for 48 hours. Had CT Scan, culture from all body fluids including CSF all WNL. She was discharge on 7-3-16 with only rash remaining.
31JUL95 MOnday; 5AM woke up hands numbs-legs itching, dizzy-problem breathing; to ER @ 6AM- given DPH IM; hives
I developed a bad rash over my upper body. My back, shoulders, chest, arms, scalp and neck. Some on midriff. This accompanied hives that came and went appearing in many places.
The morning following injections, client states, "I had a low grade fever with chills & my head was pounding in the back. My left arm wastingly & hurting down to the fingertips. I was dizzy when I stood up" x 2days, "as if my arm was asleep", client took TYLENOL q 6 hrs x 2days.
7 hours after injections, patient developed ((L) deltoid) tenderness & swelling of skin over injection site. As swelling resolved, redness spread - now 6x7cm warm, tender. Decreased range of motion of (L) deltoid to 90 degrees.
606 doses were given after expiration date; Vaccine expired on 13-Oct-2021 and was put in refrigerator on 29-Oct-2021; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 13-Oct-2021 and was put in refrigerator on 29-Oct-2021) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 13-Oct-2021 and was put in refrigerator on 29-Oct-2021). On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 13-Oct-2021 and was put in refrigerator on 29-Oct-2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  Date the vial was initially stored in the refrigerator was 29-Oct-2021. There was no temperature excursion. The reporter reported that that there was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned.  The patient did not experience any adverse event.  No treatment information was provided by the reporter.
DISCHARGE DIAGNOSIS: 1. Intractable nausea, vomiting, likely due to acute gastroenteritis.  2. Type 2 diabetes mellitus with diabetic ketoacidosis.  3. Acute on chronic thrombocytopenia, pancytopenia likely due to acute illness.  4. Acute kidney injury with history of chronic kidney disease, stage 4, likely prerenal etiology due to nausea, vomiting, diarrhea.  5. Paroxysmal atrial fibrillation.  Coumadin and aspirin held due to thrombocytopenia.  6. Coronary artery disease with history of coronary artery bypass graft.  7. History of cerebrovascular accident with mild residual left-sided weakness.  8. Hypertension and dyslipidemia.  9. Benign prostatic hyperplasia.  10. Depression.  11. NASH.
Pt recvd vax 2FEB91 & devel recurrence of nausea, vomiting & fever which were described as more severe; lab eval revealed that pt was anti-HBs neg;
Pt recvd vax 2 days later 30JUL92 exp edema of hands, aching in joints, & soreness in shoulders; 9AUG92 exp tenderness of feet & edema; In late AUG exp sloughing of skin on hands & feet; dx serum sickness; progressive systemic sclerosis;
Patient received the Pfizer Pediatric Vaccine but with 0.3ml (15 mcg) - patient will need another dose to equal the full amount
Child was given HPV #2 at 8:15 AM in the left deltoid.  Then Varicella was given in the left SQ.  We then moved to the right arm where the MCV4 was given in the right deltoid.  Immediately after MCV4 was given, child closed her eyes and complained of pain to the right arm and then fell to the side, passing out.  She was pale and sweaty and came to in about 1 minute.  She was awake and alert and responsive stating "cool, I have never passed out before".  We had her lay down for 20 minutes with her feet elevated and gave her hard candy and water to drink.  She did not have breakfast before coming to the clinic.
a strip coming up raised an inch above and below the injection site; experiencing redness which is now 4x2in which looks like sunburn on his left arm; Itchy; Burning; Real Bright Red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (a strip coming up raised an inch above and below the injection site), INJECTION SITE ERYTHEMA (experiencing redness which is now 4x2in which looks like sunburn on his left arm), PRURITUS (Itchy), INJECTION SITE PAIN (Burning) and ERYTHEMA (Real Bright Red) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced INJECTION SITE SWELLING (a strip coming up raised an inch above and below the injection site), INJECTION SITE ERYTHEMA (experiencing redness which is now 4x2in which looks like sunburn on his left arm), PRURITUS (Itchy), INJECTION SITE PAIN (Burning) and ERYTHEMA (Real Bright Red). At the time of the report, INJECTION SITE SWELLING (a strip coming up raised an inch above and below the injection site), INJECTION SITE ERYTHEMA (experiencing redness which is now 4x2in which looks like sunburn on his left arm), PRURITUS (Itchy), INJECTION SITE PAIN (Burning) and ERYTHEMA (Real Bright Red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.
Pain in shoulder (rotator cuff). Couldn't raise arm up or to the side. Severe pain. Couldn't sleep at night. It's been 9 days and I feel a lot better however, I still have pain and ice my shoulder and take ibuprofen every day. The pain seems to be lessening with each day so I did not go to see my doctor. My had also swells up with the use of that arm.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. No treatment information was reported.
I woke up with light headedness and dizziness which felt like a sinus infection, I had a sinus pressure headache and the fullness in my nose that causes pressure. I went to the Urgent Care center and they did a rapid test and a pcr test. Both came back positive. She gave me molnupiravir which I took five pills a day. I am feeling better but I still have sinus pressure and I get vertigo once in a while. The symptoms have improved but I still have the issues with my sinuses
Pt recvd rubella vax 8JUL91 on 15JUL91 exp joint discomfort, general myalgia & temp 102; nine to ten days later pt exp blotching, red small bumps on arms, trunk & face; also exp h/a, numbness;